id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02851407
|
,,,,206:217:treatment,
|
Female patients (and female partners of male patients) of childbearing potential who are sexually active must agree to use a highly effective method of contraception with their partners during exposure to defibrotide and for 1 week after the last dose of defibrotide
| 1
|
[
"Female",
"patients",
"(",
"and",
"female",
"partners",
"of",
"male",
"patients",
")",
"of",
"childbearing",
"potential",
"who",
"are",
"sexually",
"active",
"must",
"agree",
"to",
"use",
"a",
"highly",
"effective",
"method",
"of",
"contraception",
"with",
"their",
"partners",
"during",
"exposure",
"to",
"defibrotide",
"and",
"for",
"1",
"week",
"after",
"the",
"last",
"dose",
"of",
"defibrotide"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02911116
|
1:15:chronic_disease
|
Active disease is defined
| 1
|
[
"Active",
"disease",
"is",
"defined"
] |
[
2,
2,
0,
0
] |
NCT02925923
|
1:12:treatment
|
Rivaroxaban
| 1
|
[
"Rivaroxaban"
] |
[
1
] |
NCT02360579
|
,,54:76:chronic_disease,78:88:chronic_disease,130:153:chronic_disease
|
Patients ≥ 60 years of age and who have a history of ischemic heart disease, chest pain, or clinically significant atrial and/or ventricular arrhythmias must have a cardiac stress test. Patients with any irreversible wall movement abnormalities
| 1
|
[
"Patients",
"≥",
"60",
"years",
"of",
"age",
"and",
"who",
"have",
"a",
"history",
"of",
"ischemic",
"heart",
"disease",
",",
"chest",
"pain",
",",
"or",
"clinically",
"significant",
"atrial",
"and/or",
"ventricular",
"arrhythmias",
"must",
"have",
"a",
"cardiac",
"stress",
"test",
".",
"Patients",
"with",
"any",
"irreversible",
"wall",
"movement",
"abnormalities"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01059786
|
13:24:chronic_disease
|
Presence of CNS disease
| 1
|
[
"Presence",
"of",
"CNS",
"disease"
] |
[
0,
0,
2,
2
] |
NCT01915095
|
71:81:treatment
|
Able to perform some small wrist flexion and extension (measured by a goniometer)
| 1
|
[
"Able",
"to",
"perform",
"some",
"small",
"wrist",
"flexion",
"and",
"extension",
"(",
"measured",
"by",
"a",
"goniometer",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01061515
|
21:33:treatment
|
have received prior chemotherapy
| 1
|
[
"have",
"received",
"prior",
"chemotherapy"
] |
[
0,
0,
0,
1
] |
NCT02592551
|
106:115:treatment
|
Any condition that, in the opinion of the investigator, would interfere with the evaluation of the study treatment or interpretation of subject safety or study results
| 1
|
[
"Any",
"condition",
"that",
",",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
",",
"would",
"interfere",
"with",
"the",
"evaluation",
"of",
"the",
"study",
"treatment",
"or",
"interpretation",
"of",
"subject",
"safety",
"or",
"study",
"results"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02525692
|
20:39:treatment,51:60:treatment,,118:128:treatment
|
Concomitant use of CYP3A4/5 inhibitors during the treatment phase of the study and within 72 hours prior to starting study drug administration
| 1
|
[
"Concomitant",
"use",
"of",
"CYP3A4/5",
"inhibitors",
"during",
"the",
"treatment",
"phase",
"of",
"the",
"study",
"and",
"within",
"72",
"hours",
"prior",
"to",
"starting",
"study",
"drug",
"administration"
] |
[
0,
0,
0,
1,
1,
0,
0,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03102320
|
1:34:chronic_disease
|
Active hepatitis B or C infection
| 1
|
[
"Active",
"hepatitis",
"B",
"or",
"C",
"infection"
] |
[
2,
2,
2,
2,
2,
2
] |
NCT00738101
|
24:45:treatment,
|
Be expected to require intravenous nutrition for at least an additional 28 days
| 1
|
[
"Be",
"expected",
"to",
"require",
"intravenous",
"nutrition",
"for",
"at",
"least",
"an",
"additional",
"28",
"days"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02411656
|
34:62:cancer,92:95:cancer,180:188:chronic_disease,193:198:chronic_disease,200:213:chronic_disease,335:360:cancer,414:440:cancer,546:578:cancer,,
|
Has histological confirmation of HER2 normal breast carcinoma with a clinical diagnosis of IBC based on presence of inflammatory changes in the involved breast, including diffuse erythema and edema (peau d'orange), with or without an underlying palpable mass involving the majority of the skin of the breast; pathological evidence of dermal lymphatic invasion should be noted but is not required for diagnosis of inflammatory breast cancer regardless estrogen receptor (ER)/progesterone receptor (PR) status; OR has histological confirmation of triple negative breast carcinoma (HER2 normal, ER/PR < 10%) without clinical diagnosis of IBC
| 1
|
[
"Has",
"histological",
"confirmation",
"of",
"HER2",
"normal",
"breast",
"carcinoma",
"with",
"a",
"clinical",
"diagnosis",
"of",
"IBC",
"based",
"on",
"presence",
"of",
"inflammatory",
"changes",
"in",
"the",
"involved",
"breast",
",",
"including",
"diffuse",
"erythema",
"and",
"edema",
"(",
"peau",
"d'orange",
")",
",",
"with",
"or",
"without",
"an",
"underlying",
"palpable",
"mass",
"involving",
"the",
"majority",
"of",
"the",
"skin",
"of",
"the",
"breast",
";",
"pathological",
"evidence",
"of",
"dermal",
"lymphatic",
"invasion",
"should",
"be",
"noted",
"but",
"is",
"not",
"required",
"for",
"diagnosis",
"of",
"inflammatory",
"breast",
"cancer",
"regardless",
"estrogen",
"receptor",
"(",
"ER",
")",
"/progesterone",
"receptor",
"(",
"PR",
")",
"status",
";",
"OR",
"has",
"histological",
"confirmation",
"of",
"triple",
"negative",
"breast",
"carcinoma",
"(",
"HER2",
"normal",
",",
"ER/PR",
"<",
"10",
"%",
")",
"without",
"clinical",
"diagnosis",
"of",
"IBC"
] |
[
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03085784
|
18:45:treatment,62:86:cancer,122:143:chronic_disease
|
Undergone either ocular or orbital radiation for any primary ocular or orbital cancer within clinical evidence of having radiation retinopathy
| 1
|
[
"Undergone",
"either",
"ocular",
"or",
"orbital",
"radiation",
"for",
"any",
"primary",
"ocular",
"or",
"orbital",
"cancer",
"within",
"clinical",
"evidence",
"of",
"having",
"radiation",
"retinopathy"
] |
[
0,
0,
3,
3,
3,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02140255
|
11:14:chronic_disease
|
No plasma HIV RNA detected at Step 2 Week 48 and thereafter
| 1
|
[
"No",
"plasma",
"HIV",
"RNA",
"detected",
"at",
"Step",
"2",
"Week",
"48",
"and",
"thereafter"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02229565
|
15:37:treatment,79:88:treatment,92:97:treatment,101:114:treatment
|
Patients with prior systemic therapy will not be eligible for the study, i.e. radiation or chemo or immunotherapy
| 1
|
[
"Patients",
"with",
"prior",
"systemic",
"therapy",
"will",
"not",
"be",
"eligible",
"for",
"the",
"study",
",",
"i.e",
".",
"radiation",
"or",
"chemo",
"or",
"immunotherapy"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1
] |
NCT02423863
|
1:8:cancer,,
|
Sarcoma Patients must be 14 years of age or older
| 1
|
[
"Sarcoma",
"Patients",
"must",
"be",
"14",
"years",
"of",
"age",
"or",
"older"
] |
[
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02094794
|
32:42:treatment
|
the patient, family member and transplant staff physician (physician, nurse, and social worker) meet at least once prior to starting the transplant procedure
| 1
|
[
"the",
"patient",
",",
"family",
"member",
"and",
"transplant",
"staff",
"physician",
"(",
"physician",
",",
"nurse",
",",
"and",
"social",
"worker",
")",
"meet",
"at",
"least",
"once",
"prior",
"to",
"starting",
"the",
"transplant",
"procedure"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02400255
|
1:16:treatment,,,76:94:treatment,105:120:treatment,
|
Post-transplant bone marrow blast count ≤ 5% confirmed by standard of care bone marrow biopsy performed post-transplant (at least 30 days post-transplant)
| 1
|
[
"Post-transplant",
"bone",
"marrow",
"blast",
"count",
"≤",
"5",
"%",
"confirmed",
"by",
"standard",
"of",
"care",
"bone",
"marrow",
"biopsy",
"performed",
"post-transplant",
"(",
"at",
"least",
"30",
"days",
"post-transplant",
")"
] |
[
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02875405
|
1:16:chronic_disease
|
chest deformity
| 1
|
[
"chest",
"deformity"
] |
[
2,
2
] |
NCT02718001
|
15:33:treatment
|
High risk for open-heart surgery
| 1
|
[
"High",
"risk",
"for",
"open-heart",
"surgery"
] |
[
0,
0,
0,
1,
1
] |
NCT03070899
|
,49:58:treatment
|
planning a pregnancy within the duration of the treatment period of the study
| 1
|
[
"planning",
"a",
"pregnancy",
"within",
"the",
"duration",
"of",
"the",
"treatment",
"period",
"of",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02271919
|
19:39:treatment,47:69:treatment,73:96:treatment,141:151:treatment,
|
Plan to use other nicotine substitutes (i.e., over-the-counter [OTC] or prescription medication for smoking cessation) or smoking cessation treatments in the next 12 months
| 1
|
[
"Plan",
"to",
"use",
"other",
"nicotine",
"substitutes",
"(",
"i.e.",
",",
"over-the-counter",
"[",
"OTC",
"]",
"or",
"prescription",
"medication",
"for",
"smoking",
"cessation",
")",
"or",
"smoking",
"cessation",
"treatments",
"in",
"the",
"next",
"12",
"months"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02525692
|
102:108:treatment
|
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ONC201 or its excipients
| 1
|
[
"History",
"of",
"allergic",
"reactions",
"attributed",
"to",
"compounds",
"of",
"similar",
"chemical",
"or",
"biologic",
"composition",
"to",
"ONC201",
"or",
"its",
"excipients"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02412540
|
16:25:treatment,
|
Stable dose of vitamin E that was started 12 months or more prior to biopsy is allowed
| 1
|
[
"Stable",
"dose",
"of",
"vitamin",
"E",
"that",
"was",
"started",
"12",
"months",
"or",
"more",
"prior",
"to",
"biopsy",
"is",
"allowed"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03082612
|
46:58:treatment
|
Treatment plans to include weekly outpatient chemotherapy
| 1
|
[
"Treatment",
"plans",
"to",
"include",
"weekly",
"outpatient",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02564744
|
122:130:cancer
|
Participants must have evaluable or measurable disease in accordance with the International Working Group Guidelines for Lymphoma
| 1
|
[
"Participants",
"must",
"have",
"evaluable",
"or",
"measurable",
"disease",
"in",
"accordance",
"with",
"the",
"International",
"Working",
"Group",
"Guidelines",
"for",
"Lymphoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02151175
|
17:50:chronic_disease
|
Subjects with a cognitive or psychiatric disorder that limits the ability to give informed consent or are unable to cooperate with the testing
| 1
|
[
"Subjects",
"with",
"a",
"cognitive",
"or",
"psychiatric",
"disorder",
"that",
"limits",
"the",
"ability",
"to",
"give",
"informed",
"consent",
"or",
"are",
"unable",
"to",
"cooperate",
"with",
"the",
"testing"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02069925
|
10:25:chronic_disease
|
Unstable medical illness
| 1
|
[
"Unstable",
"medical",
"illness"
] |
[
0,
2,
2
] |
NCT02553642
|
,32:42:treatment,47:56:treatment,58:83:treatment,88:112:treatment
|
Must be at least 28 days since craniotomy and resection, stereotactic radiosurgery, or whole brain radiotherapy
| 1
|
[
"Must",
"be",
"at",
"least",
"28",
"days",
"since",
"craniotomy",
"and",
"resection",
",",
"stereotactic",
"radiosurgery",
",",
"or",
"whole",
"brain",
"radiotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
0,
0,
1,
1,
1
] |
NCT02188745
|
62:68:treatment,73:81:treatment,86:95:treatment
|
Baseline radiographic staging, including specifically either PET/CT, or CT (CAP) and bone scan
| 1
|
[
"Baseline",
"radiographic",
"staging",
",",
"including",
"specifically",
"either",
"PET/CT",
",",
"or",
"CT",
"(",
"CAP",
")",
"and",
"bone",
"scan"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02422641
|
,,,67:83:cancer
|
Alkaline phosphatase <2.5x the ULN or <5x the ULN if secondary to liver metastasis
| 1
|
[
"Alkaline",
"phosphatase",
"<",
"2.5x",
"the",
"ULN",
"or",
"<",
"5x",
"the",
"ULN",
"if",
"secondary",
"to",
"liver",
"metastasis"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02159027
|
9:19:cancer
|
Current malignancy
| 1
|
[
"Current",
"malignancy"
] |
[
0,
3
] |
NCT01893554
|
23:34:treatment,43:66:treatment,84:107:chronic_disease,109:118:treatment,124:143:treatment,155:171:treatment,173:192:treatment,198:223:treatment
|
Permitted concomitant medications include nutritional supplements, medications for gastroesophageal reflux, eye drops, and topical medications, including topical steroids, topical antibiotics, and topical antifungal agents
| 1
|
[
"Permitted",
"concomitant",
"medications",
"include",
"nutritional",
"supplements",
",",
"medications",
"for",
"gastroesophageal",
"reflux",
",",
"eye",
"drops",
",",
"and",
"topical",
"medications",
",",
"including",
"topical",
"steroids",
",",
"topical",
"antibiotics",
",",
"and",
"topical",
"antifungal",
"agents"
] |
[
0,
0,
1,
0,
1,
1,
0,
0,
0,
2,
2,
0,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02594111
|
1:13:treatment
|
ketoconazole
| 1
|
[
"ketoconazole"
] |
[
1
] |
NCT02477826
|
45:63:chronic_disease
|
Subjects with an active, known or suspected autoimmune disease
| 1
|
[
"Subjects",
"with",
"an",
"active",
",",
"known",
"or",
"suspected",
"autoimmune",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03059030
|
50:80:cancer
|
worsens postoperative survival in the setting of hepatocellular carcinoma (HCC)
| 1
|
[
"worsens",
"postoperative",
"survival",
"in",
"the",
"setting",
"of",
"hepatocellular",
"carcinoma",
"(",
"HCC",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0
] |
NCT02613936
|
12:21:chronic_disease
|
history of psychosis
| 1
|
[
"history",
"of",
"psychosis"
] |
[
0,
0,
2
] |
NCT02911792
|
1:27:chronic_disease
|
major organ system disease
| 1
|
[
"major",
"organ",
"system",
"disease"
] |
[
2,
2,
2,
2
] |
NCT02393794
|
1:25:chronic_disease,,
|
ncontrolled hypertension, i.e., blood pressure (BP) of ≥ 160/95
| 1
|
[
"ncontrolled",
"hypertension",
",",
"i.e.",
",",
"blood",
"pressure",
"(",
"BP",
")",
"of",
"≥",
"160/95"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02277548
|
33:50:treatment
|
Patients anticipated to receive radiation therapy with Protons
| 1
|
[
"Patients",
"anticipated",
"to",
"receive",
"radiation",
"therapy",
"with",
"Protons"
] |
[
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02508038
|
57:76:treatment
|
Is free from communicable disease risks associated with xenotransplantation
| 1
|
[
"Is",
"free",
"from",
"communicable",
"disease",
"risks",
"associated",
"with",
"xenotransplantation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01822522
|
,,,100:109:treatment
|
Hemoptysis of >= 0.5 teaspoon (2.5 mL) of red blood within 3 months before the first dose of study treatment
| 1
|
[
"Hemoptysis",
"of",
">",
"=",
"0.5",
"teaspoon",
"(",
"2.5",
"mL",
")",
"of",
"red",
"blood",
"within",
"3",
"months",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02035085
|
1:11:treatment,16:33:treatment,38:54:cancer
|
Lumpectomy and radiation therapy for breast carcinoma
| 1
|
[
"Lumpectomy",
"and",
"radiation",
"therapy",
"for",
"breast",
"carcinoma"
] |
[
1,
0,
1,
1,
0,
3,
3
] |
NCT02184520
|
1:16:chronic_disease
|
pseudoarthrosis (failed previous fusion)
| 1
|
[
"pseudoarthrosis",
"(",
"failed",
"previous",
"fusion",
")"
] |
[
2,
0,
0,
0,
0,
0
] |
NCT01495637
|
16:33:treatment
|
Presence of an endotracheal tube at the time of enrollment
| 1
|
[
"Presence",
"of",
"an",
"endotracheal",
"tube",
"at",
"the",
"time",
"of",
"enrollment"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02467478
|
16:20:treatment,24:59:treatment,71:80:treatment,85:92:treatment
|
Current use of oral or injectable anti-diabetic medication other than Metformin and insulin
| 1
|
[
"Current",
"use",
"of",
"oral",
"or",
"injectable",
"anti-diabetic",
"medication",
"other",
"than",
"Metformin",
"and",
"insulin"
] |
[
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
1,
0,
1
] |
NCT01859819
|
50:58:cancer
|
Patients with newly diagnosed Group A (low risk) lymphoma
| 1
|
[
"Patients",
"with",
"newly",
"diagnosed",
"Group",
"A",
"(",
"low",
"risk",
")",
"lymphoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02131389
|
15:38:treatment,51:55:treatment,57:89:treatment
|
Has undergone partial hip replacement or previous ORIF (open reduction internal fixation of femur or acetabulum)
| 1
|
[
"Has",
"undergone",
"partial",
"hip",
"replacement",
"or",
"previous",
"ORIF",
"(",
"open",
"reduction",
"internal",
"fixation",
"of",
"femur",
"or",
"acetabulum",
")"
] |
[
0,
0,
1,
1,
1,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03115424
|
14:41:treatment,
|
Prior use of glucose lowering medication in the 3 months prior to screening
| 1
|
[
"Prior",
"use",
"of",
"glucose",
"lowering",
"medication",
"in",
"the",
"3",
"months",
"prior",
"to",
"screening"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT00716066
|
1:14:chronic_disease,,,,
|
Renal disease with estimated glomerular filtration rate (GFR) by creatinine clearance or iothalamate clearance < 50 ml/min/1.73 m^2 body surface area
| 1
|
[
"Renal",
"disease",
"with",
"estimated",
"glomerular",
"filtration",
"rate",
"(",
"GFR",
")",
"by",
"creatinine",
"clearance",
"or",
"iothalamate",
"clearance",
"<",
"50",
"ml/min/1.73",
"m^2",
"body",
"surface",
"area"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01896999
|
46:58:treatment
|
Patients must have relapsed after first line chemotherapy
| 1
|
[
"Patients",
"must",
"have",
"relapsed",
"after",
"first",
"line",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02445768
|
9:21:chronic_disease
|
another brain injury or illness related to the brain that has lasting effects or effects experienced at the moment of recruitment
| 1
|
[
"another",
"brain",
"injury",
"or",
"illness",
"related",
"to",
"the",
"brain",
"that",
"has",
"lasting",
"effects",
"or",
"effects",
"experienced",
"at",
"the",
"moment",
"of",
"recruitment"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02518594
|
20:44:treatment,,
|
Cervical length on transvaginal examination of less than 30 mm within 10 days prior to randomization by a study certified sonographer
| 1
|
[
"Cervical",
"length",
"on",
"transvaginal",
"examination",
"of",
"less",
"than",
"30",
"mm",
"within",
"10",
"days",
"prior",
"to",
"randomization",
"by",
"a",
"study",
"certified",
"sonographer"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02332850
|
1:19:treatment,23:43:cancer,47:82:cancer,87:105:cancer,95:105:cancer,116:131:cancer,138:154:treatment
|
complete resection of basal cell carcinoma or squamous cell carcinoma of the skin, an in situ malignancy, low-risk prostate cancer after curative therapy or complete resection of other advanced malignancy with the expectation that the patient has received curative therapy
| 1
|
[
"complete",
"resection",
"of",
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"an",
"in",
"situ",
"malignancy",
",",
"low-risk",
"prostate",
"cancer",
"after",
"curative",
"therapy",
"or",
"complete",
"resection",
"of",
"other",
"advanced",
"malignancy",
"with",
"the",
"expectation",
"that",
"the",
"patient",
"has",
"received",
"curative",
"therapy"
] |
[
1,
1,
0,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
3,
3,
3,
0,
0,
3,
3,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02547662
|
13:20:chronic_disease,24:43:chronic_disease,132:141:treatment
|
Any serious medical or psychiatric illness that could, in the investigator's opinion, potentially interfere with the completion of treatment according to this protocol
| 1
|
[
"Any",
"serious",
"medical",
"or",
"psychiatric",
"illness",
"that",
"could",
",",
"in",
"the",
"investigator",
"'s",
"opinion",
",",
"potentially",
"interfere",
"with",
"the",
"completion",
"of",
"treatment",
"according",
"to",
"this",
"protocol"
] |
[
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02311621
|
1:20:cancer
|
Skull based disease with soft tissue extension
| 1
|
[
"Skull",
"based",
"disease",
"with",
"soft",
"tissue",
"extension"
] |
[
3,
3,
3,
0,
0,
0,
0
] |
NCT02746458
|
,156:175:treatment
|
Injuries to other body systems (or other medical conditions) that would preclude the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation
| 1
|
[
"Injuries",
"to",
"other",
"body",
"systems",
"(",
"or",
"other",
"medical",
"conditions",
")",
"that",
"would",
"preclude",
"the",
"ability",
"to",
"weight",
"bear",
"as",
"tolerated",
"and",
"initiate",
"PT",
"within",
"28",
"days",
"of",
"definitive",
"fixation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01896999
|
32:48:treatment
|
patients may not have received prior ipilimumab
| 1
|
[
"patients",
"may",
"not",
"have",
"received",
"prior",
"ipilimumab"
] |
[
0,
0,
0,
0,
0,
1,
1
] |
NCT01341080
|
33:55:chronic_disease
|
Subjects will be diagnosed with Parkinson Disease (PD) by the UK Brain Bank criteria
| 1
|
[
"Subjects",
"will",
"be",
"diagnosed",
"with",
"Parkinson",
"Disease",
"(",
"PD",
")",
"by",
"the",
"UK",
"Brain",
"Bank",
"criteria"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02920086
|
1:19:chronic_disease,11:19:chronic_disease,132:145:chronic_disease
|
End-stage dementia (inability to perform all ADLs, mutism or minimal verbal output secondary to dementia, bed-bound state prior to acute illness)
| 1
|
[
"End-stage",
"dementia",
"(",
"inability",
"to",
"perform",
"all",
"ADLs",
",",
"mutism",
"or",
"minimal",
"verbal",
"output",
"secondary",
"to",
"dementia",
",",
"bed-bound",
"state",
"prior",
"to",
"acute",
"illness",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT02383927
|
,,27:51:chronic_disease
|
NYHA Grade III or greater congestive heart failure
| 1
|
[
"NYHA",
"Grade",
"III",
"or",
"greater",
"congestive",
"heart",
"failure"
] |
[
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02809677
|
11:43:chronic_disease,67:93:chronic_disease,100:124:chronic_disease,126:141:chronic_disease,143:170:chronic_disease,175:181:cancer,222:228:chronic_disease,230:237:chronic_disease,239:249:chronic_disease
|
severe or life-threatening medical illness, such as other serious cardiopulmonary conditions (e.g. congenital heart disease, cystic fibrosis, alpha-1-antitrypsin disease) or cancer, which would confound the assessment of asthma, anxiety, depression or quality of life
| 1
|
[
"severe",
"or",
"life-threatening",
"medical",
"illness",
",",
"such",
"as",
"other",
"serious",
"cardiopulmonary",
"conditions",
"(",
"e.g",
".",
"congenital",
"heart",
"disease",
",",
"cystic",
"fibrosis",
",",
"alpha-1-antitrypsin",
"disease",
")",
"or",
"cancer",
",",
"which",
"would",
"confound",
"the",
"assessment",
"of",
"asthma",
",",
"anxiety",
",",
"depression",
"or",
"quality",
"of",
"life"
] |
[
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
0,
0,
0,
0
] |
NCT01622868
|
7:26:cancer,35:63:cancer,85:112:cancer,144:151:cancer,167:180:cancer,
|
Prior invasive malignancy (except non-melanomatous skin cancer, curatively resected thyroid papillary carcinoma, and invasive and non-invasive cancers related to the breast cancer) unless disease free for a minimum of 3 years
| 1
|
[
"Prior",
"invasive",
"malignancy",
"(",
"except",
"non-melanomatous",
"skin",
"cancer",
",",
"curatively",
"resected",
"thyroid",
"papillary",
"carcinoma",
",",
"and",
"invasive",
"and",
"non-invasive",
"cancers",
"related",
"to",
"the",
"breast",
"cancer",
")",
"unless",
"disease",
"free",
"for",
"a",
"minimum",
"of",
"3",
"years"
] |
[
0,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02315612
|
1:21:treatment,39:58:treatment,60:74:treatment
|
immunohistochemistry will be used for lymph node biopsies, flow cytometry will be used for peripheral blood and bone marrow samples and CSF when feasible
| 1
|
[
"immunohistochemistry",
"will",
"be",
"used",
"for",
"lymph",
"node",
"biopsies",
",",
"flow",
"cytometry",
"will",
"be",
"used",
"for",
"peripheral",
"blood",
"and",
"bone",
"marrow",
"samples",
"and",
"CSF",
"when",
"feasible"
] |
[
1,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03042767
|
1:14:chronic_disease,,,
|
Acute illness within past 2 weeks prior to enrollment (defined as fever > 100.4ºF)
| 1
|
[
"Acute",
"illness",
"within",
"past",
"2",
"weeks",
"prior",
"to",
"enrollment",
"(",
"defined",
"as",
"fever",
">",
"100.4ºF",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01896999
|
,,114:128:treatment
|
a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation
| 1
|
[
"a",
"female",
"of",
"childbearing",
"potential",
"is",
"any",
"woman",
",",
"regardless",
"of",
"sexual",
"orientation",
"or",
"whether",
"they",
"have",
"undergone",
"tubal",
"ligation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02008656
|
4:21:chronic_disease,32:61:treatment,63:79:treatment
|
No active infections requiring systemic antibiotic treatment (oral antibiotics are acceptable at the discretion of the treating physician)
| 1
|
[
"No",
"active",
"infections",
"requiring",
"systemic",
"antibiotic",
"treatment",
"(",
"oral",
"antibiotics",
"are",
"acceptable",
"at",
"the",
"discretion",
"of",
"the",
"treating",
"physician",
")"
] |
[
0,
2,
2,
0,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00540761
|
13:46:chronic_disease
|
unprotected left main coronary artery disease
| 1
|
[
"unprotected",
"left",
"main",
"coronary",
"artery",
"disease"
] |
[
0,
2,
2,
2,
2,
2
] |
NCT01829958
|
1:16:chronic_disease,18:33:chronic_disease,37:55:chronic_disease
|
Serous effusion (plural effusion or peritoneal ascites)
| 1
|
[
"Serous",
"effusion",
"(",
"plural",
"effusion",
"or",
"peritoneal",
"ascites",
")"
] |
[
2,
2,
0,
2,
2,
0,
2,
2,
0
] |
NCT02370693
|
33:43:allergy_name,45:50:allergy_name,54:62:allergy_name
|
Patient has hypersensitivity to bortezomib, boron or mannitol
| 1
|
[
"Patient",
"has",
"hypersensitivity",
"to",
"bortezomib",
",",
"boron",
"or",
"mannitol"
] |
[
0,
0,
0,
0,
4,
0,
4,
0,
4
] |
NCT03036280
|
1:22:chronic_disease,42:56:chronic_disease,58:74:chronic_disease,76:85:chronic_disease
|
Psychiatric diagnosis or symptoms (e.g., hallucinations, major depression, delusions, etc.)
| 1
|
[
"Psychiatric",
"diagnosis",
"or",
"symptoms",
"(",
"e.g.",
",",
"hallucinations",
",",
"major",
"depression",
",",
"delusions",
",",
"etc",
".",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
2,
0,
0,
0,
0
] |
NCT02536794
|
38:56:chronic_disease
|
Patients with a history of or active autoimmune disease
| 1
|
[
"Patients",
"with",
"a",
"history",
"of",
"or",
"active",
"autoimmune",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02488967
|
27:40:cancer
|
By pathologic evaluation, primary tumor must be pT1-3
| 1
|
[
"By",
"pathologic",
"evaluation",
",",
"primary",
"tumor",
"must",
"be",
"pT1-3"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
0
] |
NCT02479620
|
1:14:chronic_disease
|
osteomyelitis of the metatarsal or more proximal region
| 1
|
[
"osteomyelitis",
"of",
"the",
"metatarsal",
"or",
"more",
"proximal",
"region"
] |
[
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01880567
|
16:27:chronic_disease
|
positive serum hepatitis B antibody
| 1
|
[
"positive",
"serum",
"hepatitis",
"B",
"antibody"
] |
[
0,
0,
2,
2,
0
] |
NCT02520791
|
43:61:chronic_disease
|
Patients with active, known, or suspected autoimmune disease
| 1
|
[
"Patients",
"with",
"active",
",",
"known",
",",
"or",
"suspected",
"autoimmune",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02251431
|
1:24:treatment
|
Prior bariatric surgery
| 1
|
[
"Prior",
"bariatric",
"surgery"
] |
[
1,
1,
1
] |
NCT02479698
|
12:34:treatment
|
history of solid organ transplant
| 1
|
[
"history",
"of",
"solid",
"organ",
"transplant"
] |
[
0,
0,
1,
1,
1
] |
NCT01585402
|
33:37:chronic_disease
|
Subjects must be diagnosed with ACDC based on genetic tests confirming mutation(s) in NT5E and evidence of lower extremity arterial calcifications
| 1
|
[
"Subjects",
"must",
"be",
"diagnosed",
"with",
"ACDC",
"based",
"on",
"genetic",
"tests",
"confirming",
"mutation",
"(",
"s",
")",
"in",
"NT5E",
"and",
"evidence",
"of",
"lower",
"extremity",
"arterial",
"calcifications"
] |
[
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02975986
|
22:27:treatment,25:27:treatment,,58:79:chronic_disease,,,107:118:treatment,120:150:treatment,170:186:chronic_disease,203:216:chronic_disease,,,,,368:374:chronic_disease,380:447:treatment,456:480:treatment
|
Contraindications to SPECT/CT, pregnancy, breastfeeding, chronic renal disease (eGFR < 60 ml/min/1.73m2), proteinuria, genetic diseases of the kidney, inborn defects of lipid metabolism, alcohol abuse, liver disease (patients with highly elevated total bilirubin, elevated liver enzymes AST, ALT and alkaline phosphatase and those with an established liver disease), anemia, and pharmacological treatment with insulin or insulin-sensitizing drugs such as thiazolidinediones (TZD)
| 1
|
[
"Contraindications",
"to",
"SPECT/CT",
",",
"pregnancy",
",",
"breastfeeding",
",",
"chronic",
"renal",
"disease",
"(",
"eGFR",
"<",
"60",
"ml/min/1.73m2",
")",
",",
"proteinuria",
",",
"genetic",
"diseases",
"of",
"the",
"kidney",
",",
"inborn",
"defects",
"of",
"lipid",
"metabolism",
",",
"alcohol",
"abuse",
",",
"liver",
"disease",
"(",
"patients",
"with",
"highly",
"elevated",
"total",
"bilirubin",
",",
"elevated",
"liver",
"enzymes",
"AST",
",",
"ALT",
"and",
"alkaline",
"phosphatase",
"and",
"those",
"with",
"an",
"established",
"liver",
"disease",
")",
",",
"anemia",
",",
"and",
"pharmacological",
"treatment",
"with",
"insulin",
"or",
"insulin-sensitizing",
"drugs",
"such",
"as",
"thiazolidinediones",
"(",
"TZD",
")"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
1,
1,
0,
0
] |
NCT01871766
|
,,,,,,143:152:treatment
|
Female participants ≥ 10 years of age or post-menarchal must have a negative serum or urine pregnancy test within 24 hours prior to beginning treatment
| 1
|
[
"Female",
"participants",
"≥",
"10",
"years",
"of",
"age",
"or",
"post-menarchal",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"within",
"24",
"hours",
"prior",
"to",
"beginning",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02508038
|
8:46:chronic_disease
|
active Central Nervous System (CNS) infection
| 1
|
[
"active",
"Central",
"Nervous",
"System",
"(",
"CNS",
")",
"infection"
] |
[
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT01970306
|
47:64:allergy_name
|
Patients with known sensitivity or allergy to porcine materials
| 1
|
[
"Patients",
"with",
"known",
"sensitivity",
"or",
"allergy",
"to",
"porcine",
"materials"
] |
[
0,
0,
0,
0,
0,
0,
0,
4,
4
] |
NCT02101034
|
,,71:81:cancer,85:120:cancer,145:160:treatment,167:198:cancer
|
A history of other malignancy ≤ 1 year previous with the exception of basal cell or squamous cell carcinoma of the skin which were treated with local resection only, carcinoma in situ of the cervix, or synchronous H&N primaries
| 1
|
[
"A",
"history",
"of",
"other",
"malignancy",
"≤",
"1",
"year",
"previous",
"with",
"the",
"exception",
"of",
"basal",
"cell",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"which",
"were",
"treated",
"with",
"local",
"resection",
"only",
",",
"carcinoma",
"in",
"situ",
"of",
"the",
"cervix",
",",
"or",
"synchronous",
"H",
"&",
"N",
"primaries"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02162420
|
1:16:chronic_disease
|
Acute hepatitis
| 1
|
[
"Acute",
"hepatitis"
] |
[
2,
2
] |
NCT02579044
|
,,109:134:treatment
|
It is permissible for female subjects to take oral contraceptives or other hormonal methods while receiving treatment with everolimus
| 1
|
[
"It",
"is",
"permissible",
"for",
"female",
"subjects",
"to",
"take",
"oral",
"contraceptives",
"or",
"other",
"hormonal",
"methods",
"while",
"receiving",
"treatment",
"with",
"everolimus"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02527200
|
1:32:chronic_disease
|
Type 2 diabetes mellitus (T2DM)
| 1
|
[
"Type",
"2",
"diabetes",
"mellitus",
"(",
"T2DM",
")"
] |
[
2,
2,
2,
2,
2,
0,
0
] |
NCT02304458
|
47:63:cancer
|
Part D3: Patients with relapsed or refractory rhabdomyosarcoma
| 1
|
[
"Part",
"D3",
":",
"Patients",
"with",
"relapsed",
"or",
"refractory",
"rhabdomyosarcoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02256631
|
47:50:chronic_disease,,
|
Mother with any detectable viral replication (HIV RNA above the limit of detection) at last measurement prior to delivery determined within 30 days of delivery
| 1
|
[
"Mother",
"with",
"any",
"detectable",
"viral",
"replication",
"(",
"HIV",
"RNA",
"above",
"the",
"limit",
"of",
"detection",
")",
"at",
"last",
"measurement",
"prior",
"to",
"delivery",
"determined",
"within",
"30",
"days",
"of",
"delivery"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02578901
|
71:80:treatment
|
Having been previously randomized in this study at any stage of their treatment
| 1
|
[
"Having",
"been",
"previously",
"randomized",
"in",
"this",
"study",
"at",
"any",
"stage",
"of",
"their",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01959204
|
26:34:treatment
|
Has an indwelling access catheter for blood sampling
| 1
|
[
"Has",
"an",
"indwelling",
"access",
"catheter",
"for",
"blood",
"sampling"
] |
[
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02464696
|
18:28:cancer
|
Have a diagnosed malignancy
| 1
|
[
"Have",
"a",
"diagnosed",
"malignancy"
] |
[
0,
0,
0,
3
] |
NCT01893307
|
1:6:cancer,26:45:cancer,61:88:chronic_disease
|
Tumor tissue (primary or cervical metastasis) available for human papilloma virus (HPV)
| 1
|
[
"Tumor",
"tissue",
"(",
"primary",
"or",
"cervical",
"metastasis",
")",
"available",
"for",
"human",
"papilloma",
"virus",
"(",
"HPV",
")"
] |
[
3,
0,
0,
0,
0,
3,
3,
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT01989585
|
38:60:treatment,85:106:treatment,,,245:254:treatment
|
Patients who are receiving any other investigational agents have received any other investigational drugs within 28 days (or five half-lives, whichever is shorter; with a minimum of 14 days from the last dose) preceding the first dose of study treatment and during the study
| 1
|
[
"Patients",
"who",
"are",
"receiving",
"any",
"other",
"investigational",
"agents",
"have",
"received",
"any",
"other",
"investigational",
"drugs",
"within",
"28",
"days",
"(",
"or",
"five",
"half-lives",
",",
"whichever",
"is",
"shorter",
";",
"with",
"a",
"minimum",
"of",
"14",
"days",
"from",
"the",
"last",
"dose",
")",
"preceding",
"the",
"first",
"dose",
"of",
"study",
"treatment",
"and",
"during",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02496585
|
7:30:treatment,
|
Other investigational therapy received within 8 weeks prior to screening visit
| 1
|
[
"Other",
"investigational",
"therapy",
"received",
"within",
"8",
"weeks",
"prior",
"to",
"screening",
"visit"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01763970
|
,,79:88:treatment
|
refusal of women of child bearing potential to take a pregnancy test prior to treatment
| 1
|
[
"refusal",
"of",
"women",
"of",
"child",
"bearing",
"potential",
"to",
"take",
"a",
"pregnancy",
"test",
"prior",
"to",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02449980
|
,,,70:82:chronic_disease
|
Children ages 5 to 18 with clinical diagnosis of primary spontaneous pneumothorax (symptoms of chest pain and/or shortness of breath and pneumothorax demonstrated on chest radiograph) and no prior history of pneumothorax
| 1
|
[
"Children",
"ages",
"5",
"to",
"18",
"with",
"clinical",
"diagnosis",
"of",
"primary",
"spontaneous",
"pneumothorax",
"(",
"symptoms",
"of",
"chest",
"pain",
"and/or",
"shortness",
"of",
"breath",
"and",
"pneumothorax",
"demonstrated",
"on",
"chest",
"radiograph",
")",
"and",
"no",
"prior",
"history",
"of",
"pneumothorax"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02762266
|
,,37:46:treatment
|
with score =< 9 ((within 4 weeks of treatment)
| 1
|
[
"with",
"score",
"=",
"<",
"9",
"(",
"(",
"within",
"4",
"weeks",
"of",
"treatment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01925378
|
28:39:chronic_disease,44:60:chronic_disease,76:93:chronic_disease
|
Patients with a chronic or acute renal, or hepatic disorder, a significant bleeding disorder, or any other condition which in the Investigator's opinion might preclude study participation for the duration of the trial
| 1
|
[
"Patients",
"with",
"a",
"chronic",
"or",
"acute",
"renal",
",",
"or",
"hepatic",
"disorder",
",",
"a",
"significant",
"bleeding",
"disorder",
",",
"or",
"any",
"other",
"condition",
"which",
"in",
"the",
"Investigator",
"'s",
"opinion",
"might",
"preclude",
"study",
"participation",
"for",
"the",
"duration",
"of",
"the",
"trial"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01639508
|
,,,,,342:355:treatment,,,,
|
The subject is capable of understanding and complying with the protocol requirements and has signed the informed consent document. Sexually active subjects (men and women) must agree to use medically accepted barrier methods of contraception (eg, male or female condom) during the course of the study and for 4 months after the last dose of study drug(s), even if oral contraceptives are also used. All subjects of reproductive potential must agree to use both a barrier method and a second method of birth control. Women of childbearing potential must have a negative pregnancy test at screening
| 1
|
[
"The",
"subject",
"is",
"capable",
"of",
"understanding",
"and",
"complying",
"with",
"the",
"protocol",
"requirements",
"and",
"has",
"signed",
"the",
"informed",
"consent",
"document",
".",
"Sexually",
"active",
"subjects",
"(",
"men",
"and",
"women",
")",
"must",
"agree",
"to",
"use",
"medically",
"accepted",
"barrier",
"methods",
"of",
"contraception",
"(",
"eg",
",",
"male",
"or",
"female",
"condom",
")",
"during",
"the",
"course",
"of",
"the",
"study",
"and",
"for",
"4",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"drug",
"(",
"s",
")",
",",
"even",
"if",
"oral",
"contraceptives",
"are",
"also",
"used",
".",
"All",
"subjects",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"both",
"a",
"barrier",
"method",
"and",
"a",
"second",
"method",
"of",
"birth",
"control",
".",
"Women",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"at",
"screening"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.